Reduce blood culture contamination
Steripath® Gen2 Initial Specimen Diversion Device®(ISDD®) is the only technology of its kind supported by independent published clinical study results. These studies have demonstrated blood culture contamination rates as low as 0.2% in the ED, sustained for 12 months.1 With improved test results, patients can benefit from reduced risk of sepsis misdiagnoses and unnecessary antibiotic treatment.
A Contaminated Blood Culture
Blood culture collection remains the gold standard for diagnosing bloodstream infections and sepsis– the leading cause of death and readmission in US hospitals. Even with best practices, between 35-50% of positive blood culture results are contaminated, resulting in false-positive diagnoses that place over one million lives at risk each year.2
1. M. Rupp, et al; Reduction in Blood Culture Contamination Through Use of Initial Specimen Diversion Device. Clinical Infectious Diseases (August 2017)
2. Alahmadi Y.M, M.A. Aldeyab, J.C. McElnay, M.G. Scott, F.W. Darwish Elhajji, F.A. Magee, et al. Clinical and economic impact of contaminated blood cultures within the hospital setting. J Hosp Infect. 2011 Mar; 77(3): 233-6.